These “living therapeutics” can sustain themselves in vivo and survive in biological environments including tumors, inflamed ...

The CHOP's research team findings support the hypothesis that rare AAV integration can contribute to human oncogenesis, which ...

The new CRISPR platform, called ΨDNA, reprograms Cas12 nucleases to recognize and act on RNA using a DNA-based guide scaffold ...

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...

CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the same quarter last year, ...

When these anchors are attached to cancer drugs, they attach to cell membranes and shrink tumors better than unmodified drug ...

The data shows that immune cells converge at sites of motor neuron loss and TDP-43 pathology with distinct patterns depending on the ALS type.

Sickle cell warrior Victoria Gray, the first patient to enroll in the Casgevy gene editing trial, shared some highs and lows ...

In tests gadusol showed antioxidant activity comparable to that of vitamin C, suggesting it may help neutralize cell-damaging free radicals from UV exposure.

One of the winners of the 2026 ASGCT Catalyst Award, Kiran Musunuru, MD, PhD, delivered a sobering lecture on the legacy of ...

Dravet syndrome has long represented one of the most challenging pediatric epilepsies encountered in neurology and genetic medicine. Caused primarily by loss‑of‑function variants in SCN1A, the ...

Researchers at the University of Pennsylvania developed ApexGO, an AI-powered system that optimizes antimicrobial peptides.